FOXP1 and endothelial dysfunction: A comparison was made of the nitric oxide (NO, a marker of endothelial dysfunction) 33 concentration in the serum, and treatment with AAV9-FOXP1 significantly increased NO levels compared to AAV-con (Figure 4C).